Similarly, exosomal-EphA2 has been reported to facilitate cell migration in pancreatic cancer, and levels of serum exo-EphA2 are significantly higher in pancreatic cancer patients compared to those with benign pancreatic disease or healthy controls 75. The gene discussed is EPHA2; the disease is familial pancreatic carcinoma.